14/10/2026
A great afternoon with Identifai Genetics (ASX: ID1).
Today’s investor lunch was one of our best sessions so far. It was great to have many of our clients join us to hear directly from the team.
CEO Eyal Miller and Professor Noam Shomron shared the story behind Windrose, the opportunity they’re pursuing, and the milestones ahead. The questions and discussion made for a terrific event.
ID1 listed yesterday and has made a strong start on the ASX. We’ll be watching how the team progresses its clinical validation and commercialisation plans.
Thanks to Eyal, Noam and the Identifai team, and to our clients who joined us.